Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series

Dupilumab is the first biologic registered for the treatment of atopic dermatitis (AD). We report on seven patients with AD presenting with a paradoxical head and neck erythema that appeared 10–39 weeks after the start of dupilumab treatment. The patients presented with a relatively sharply demarcat...

Descripción completa

Detalles Bibliográficos
Autores principales: de Wijs, L.E.M., Nguyen, N.T., Kunkeler, A.C.M., Nijsten, T., Damman, J., Hijnen, D.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586932/
https://www.ncbi.nlm.nih.gov/pubmed/31749159
http://dx.doi.org/10.1111/bjd.18730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586932/
https://www.ncbi.nlm.nih.gov/pubmed/31749159
http://dx.doi.org/10.1111/bjd.18730

Ejemplares similares